{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:50:34Z","timestamp":1792122634155,"version":"4.4.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11154-024-09915-8","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:02:18Z","timestamp":1730300538000},"page":"953-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prolactin: structure, receptors, and functions"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2228-9437","authenticated-orcid":false,"given":"Fanny","family":"Chasseloup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2898-0381","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5096-5722","authenticated-orcid":false,"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"issue":"2","key":"9915_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/j.1460-2075.1984.tb01824.x","volume":"3","author":"AT Truong","year":"1984","unstructured":"Truong AT, Duez C, Belayew A, Renard A, Pictet R, Bell GI, et al. Isolation and characterization of the human prolactin gene. EMBO J. 1984;3(2):429\u201337. https:\/\/doi.org\/10.1002\/j.1460-2075.1984.tb01824.x.","journal-title":"EMBO J"},{"issue":"5","key":"9915_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/edrv-15-5-627","volume":"15","author":"ND Horseman","year":"1994","unstructured":"Horseman ND, Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr Rev. 1994;15(5):627\u201349. https:\/\/doi.org\/10.1210\/edrv-15-5-627.","journal-title":"Endocr Rev"},{"issue":"1\u20132","key":"9915_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2007.06.001","volume":"276","author":"AM Walker","year":"2007","unstructured":"Walker AM. S179D prolactin: antagonistic agony! Mol Cell Endocrinol. 2007;276(1\u20132):1\u20139. https:\/\/doi.org\/10.1016\/j.mce.2007.06.001.","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"9915_CR4","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523\u2013631. https:\/\/doi.org\/10.1152\/physrev.2000.80.4.1523.","journal-title":"Physiol Rev"},{"issue":"5","key":"9915_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","volume":"27","author":"M Fahie-Wilson","year":"2013","unstructured":"Fahie-Wilson M, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab. 2013;27(5):725\u201342. https:\/\/doi.org\/10.1016\/j.beem.2013.07.002.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"9915_CR6","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D. The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab. 2019;33(2):101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"9915_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tem.2006.08.002","volume":"17","author":"C Clapp","year":"2006","unstructured":"Clapp C, Aranda J, Gonzalez C, Jeziorski MC, Martinez de la Escalera G. Vasoinhibins: endogenous regulators of angiogenesis and vascular function. Trends Endocrinol Metab. 2006;17(8):301\u20137. https:\/\/doi.org\/10.1016\/j.tem.2006.08.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"9915_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1210\/endo.130.3.1311239","volume":"130","author":"C Clapp","year":"1992","unstructured":"Clapp C, Weiner RI. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells. Endocrinology. 1992;130(3):1380\u20136. https:\/\/doi.org\/10.1210\/endo.130.3.1311239.","journal-title":"Endocrinology"},{"issue":"Pt 9","key":"9915_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1242\/jcs.02887","volume":"119","author":"Y Macotela","year":"2006","unstructured":"Macotela Y, Aguilar MB, Guzman-Morales J, Rivera JC, Zermeno C, Lopez-Barrera F, et al. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16\u00a0kDa prolactin. J Cell Sci. 2006;119(Pt 9):1790\u2013800. https:\/\/doi.org\/10.1242\/jcs.02887.","journal-title":"J Cell Sci"},{"issue":"3","key":"9915_CR10","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1210\/endo.133.3.7689950","volume":"133","author":"C Clapp","year":"1993","unstructured":"Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology. 1993;133(3):1292\u20139. https:\/\/doi.org\/10.1210\/endo.133.3.7689950.","journal-title":"Endocrinology"},{"key":"9915_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000094309","volume":"35","author":"C Clapp","year":"2006","unstructured":"Clapp C, Gonzalez C, Macotela Y, Aranda J, Rivera JC, Garcia C, et al. Vasoinhibins: a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function. Front Horm Res. 2006;35:64\u201373. https:\/\/doi.org\/10.1159\/000094309.","journal-title":"Front Horm Res"},{"issue":"4","key":"9915_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF00220215","volume":"158","author":"NS Halmi","year":"1975","unstructured":"Halmi NS, Parsons JA, Erlandsen SL, Duello T. Prolactin and growth hormone cells in the human hypophysis: a study with immunoenzyme histochemistry and differential staining. Cell Tissue Res. 1975;158(4):497\u2013507. https:\/\/doi.org\/10.1007\/BF00220215.","journal-title":"Cell Tissue Res"},{"key":"9915_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/ncomms1612","volume":"3","author":"DJ Hodson","year":"2012","unstructured":"Hodson DJ, Schaeffer M, Romano N, Fontanaud P, Lafont C, Birkenstock J, et al. Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nat Commun. 2012;3:605. https:\/\/doi.org\/10.1038\/ncomms1612.","journal-title":"Nat Commun"},{"issue":"3","key":"9915_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-09-0923","volume":"162","author":"Z Karaca","year":"2010","unstructured":"Karaca Z, Tanriverdi F, Unluhizarci K, Kelestimur F. Pregnancy and pituitary disorders. Eur J Endocrinol. 2010;162(3):453\u201375. https:\/\/doi.org\/10.1530\/EJE-09-0923.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9915_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/j.1365-2826.2008.01736.x","volume":"20","author":"DR Grattan","year":"2008","unstructured":"Grattan DR, Kokay IC. Prolactin: a pleiotropic neuroendocrine hormone. J Neuroendocrinol. 2008;20(6):752\u201363. https:\/\/doi.org\/10.1111\/j.1365-2826.2008.01736.x.","journal-title":"J Neuroendocrinol"},{"issue":"9","key":"9915_CR16","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1096\/fj.201701111RR","volume":"32","author":"V Bernard","year":"2018","unstructured":"Bernard V, Lamothe S, Beau I, Guillou A, Martin A, Le Tissier P, et al. Autocrine actions of prolactin contribute to the regulation of lactotroph function in vivo. FASEB J. 2018;32(9):4791\u20137. https:\/\/doi.org\/10.1096\/fj.201701111RR.","journal-title":"FASEB J"},{"issue":"7","key":"9915_CR17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1172\/jci15912","volume":"110","author":"KG Schuff","year":"2002","unstructured":"Schuff KG, Hentges ST, Kelly MA, Binart N, Kelly PA, Iuvone PM, et al. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest. 2002;110(7):973\u201381. https:\/\/doi.org\/10.1172\/jci15912.","journal-title":"J Clin Invest"},{"issue":"1","key":"9915_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s0896-6273(00)80351-7","volume":"19","author":"MA Kelly","year":"1997","unstructured":"Kelly MA, Rubinstein M, Asa SL, Zhang G, Saez C, Bunzow JR, et al. Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron. 1997;19(1):103\u201313. https:\/\/doi.org\/10.1016\/s0896-6273(00)80351-7.","journal-title":"Neuron"},{"issue":"11","key":"9915_CR19","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/endo.140.11.7118","volume":"140","author":"SL Asa","year":"1999","unstructured":"Asa SL, Kelly MA, Grandy DK, Low MJ. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology. 1999;140(11):5348\u201355. https:\/\/doi.org\/10.1210\/endo.140.11.7118.","journal-title":"Endocrinology"},{"issue":"5","key":"9915_CR20","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.18632\/oncotarget.23713","volume":"9","author":"V Bernard","year":"2018","unstructured":"Bernard V, Villa C, Auguste A, Lamothe S, Guillou A, Martin A, et al. Natural and molecular history of prolactinoma: insights from a Prlr(-\/-) mouse model. Oncotarget. 2018;9(5):6144\u201355. https:\/\/doi.org\/10.18632\/oncotarget.23713.","journal-title":"Oncotarget"},{"issue":"1","key":"9915_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1023\/a:1026229810876","volume":"6","author":"LG Sobrinho","year":"2003","unstructured":"Sobrinho LG. Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary. 2003;6(1):35\u20139. https:\/\/doi.org\/10.1023\/a:1026229810876.","journal-title":"Pituitary"},{"key":"9915_CR22","doi-asserted-by":"publisher","first-page":"1369729","DOI":"10.3389\/fendo.2024.1369729","volume":"15","author":"X Miao","year":"2024","unstructured":"Miao X, Fu Z, Luo X, Wang J, Yuan L, Zhao S, et al. A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma. Front Endocrinol (Lausanne). 2024;15:1369729. https:\/\/doi.org\/10.3389\/fendo.2024.1369729.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"9915_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023;19(12):722\u201340. https:\/\/doi.org\/10.1038\/s41574-023-00886-5.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"9915_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1210\/edrv-17-6-639","volume":"17","author":"N Ben-Jonathan","year":"1996","unstructured":"Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996;17(6):639\u201369. https:\/\/doi.org\/10.1210\/edrv-17-6-639.","journal-title":"Endocr Rev"},{"issue":"4","key":"9915_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","volume":"9","author":"T Brandebourg","year":"2007","unstructured":"Brandebourg T, Hugo E, Ben-Jonathan N. Adipocyte prolactin: regulation of release and putative functions. Diabetes Obes Metab. 2007;9(4):464\u201376. https:\/\/doi.org\/10.1111\/j.1463-1326.2006.00671.x.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"9915_CR26","doi-asserted-by":"publisher","first-page":"e63952","DOI":"10.1371\/journal.pone.0063952","volume":"8","author":"RJ Marano","year":"2013","unstructured":"Marano RJ, Tickner J, Redmond SL. Prolactin expression in the cochlea of aged BALB\/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. PLoS ONE. 2013;8(5):e63952. https:\/\/doi.org\/10.1371\/journal.pone.0063952.","journal-title":"PLoS ONE"},{"issue":"9","key":"9915_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.tem.2010.06.001","volume":"21","author":"EA Langan","year":"2010","unstructured":"Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R. Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab. 2010;21(9):569\u201377. https:\/\/doi.org\/10.1016\/j.tem.2010.06.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"9915_CR28","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1210\/endo-128-6-2776","volume":"128","author":"E Nagy","year":"1991","unstructured":"Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology. 1991;128(6):2776\u201384. https:\/\/doi.org\/10.1210\/endo-128-6-2776.","journal-title":"Endocrinology"},{"issue":"3","key":"9915_CR29","first-page":"333","volume":"50","author":"GC Lachelin","year":"1977","unstructured":"Lachelin GC, Yen SC, Alksne JF. Hormonal changes following hypophysectomy in humans. Obstet Gynecol. 1977;50(3):333\u20139.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"9915_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/me.2013-1349","volume":"28","author":"RJ Marano","year":"2014","unstructured":"Marano RJ, Ben-Jonathan N, Minireview. Extrapituitary prolactin: an update on the distribution, regulation, and functions. Mol Endocrinol. 2014;28(5):622\u201333. https:\/\/doi.org\/10.1210\/me.2013-1349.","journal-title":"Mol Endocrinol"},{"issue":"19","key":"9915_CR31","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1101\/gad.197343.112","volume":"26","author":"CC Chen","year":"2012","unstructured":"Chen CC, Stairs DB, Boxer RB, Belka GK, Horseman ND, Alvarez JV, et al. Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the akt and Stat5 pathways. Genes Dev. 2012;26(19):2154\u201368. https:\/\/doi.org\/10.1101\/gad.197343.112.","journal-title":"Genes Dev"},{"key":"9915_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2148-7-120","volume":"7","author":"C Liongue","year":"2007","unstructured":"Liongue C, Ward AC. Evolution of Class I cytokine receptors. BMC Evol Biol. 2007;7:120. https:\/\/doi.org\/10.1186\/1471-2148-7-120.","journal-title":"BMC Evol Biol"},{"key":"9915_CR33","doi-asserted-by":"publisher","first-page":"11578","DOI":"10.1038\/ncomms11578","volume":"7","author":"K Bugge","year":"2016","unstructured":"Bugge K, Papaleo E, Haxholm GW, Hopper JT, Robinson CV, Olsen JG, et al. A combined computational and structural model of the full-length human prolactin receptor. Nat Commun. 2016;7:11578. https:\/\/doi.org\/10.1038\/ncomms11578.","journal-title":"Nat Commun"},{"issue":"3","key":"9915_CR34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","volume":"19","author":"C Bole-Feysot","year":"1998","unstructured":"Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998;19(3):225\u201368. https:\/\/doi.org\/10.1210\/edrv.19.3.0334.","journal-title":"Endocr Rev"},{"issue":"50","key":"9915_CR35","doi-asserted-by":"publisher","first-page":"35461","DOI":"10.1074\/jbc.274.50.35461","volume":"274","author":"JB Kline","year":"1999","unstructured":"Kline JB, Roehrs H, Clevenger CV. Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem. 1999;274(50):35461\u20138. https:\/\/doi.org\/10.1074\/jbc.274.50.35461.","journal-title":"J Biol Chem"},{"key":"9915_CR36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/978-1-4757-4242-8_71","volume":"554","author":"JF Trott","year":"2004","unstructured":"Trott JF, Hovey RC, Koduri S, Vonderhaar BK. Multiple new isoforms of the human prolactin receptor gene. Adv Exp Med Biol. 2004;554:495\u20139. https:\/\/doi.org\/10.1007\/978-1-4757-4242-8_71.","journal-title":"Adv Exp Med Biol"},{"issue":"44","key":"9915_CR37","doi-asserted-by":"publisher","first-page":"41086","DOI":"10.1074\/jbc.M102109200","volume":"276","author":"ZZ Hu","year":"2001","unstructured":"Hu ZZ, Meng J, Dufau ML. Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem. 2001;276(44):41086\u201394. https:\/\/doi.org\/10.1074\/jbc.M102109200.","journal-title":"J Biol Chem"},{"issue":"15","key":"9915_CR38","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1073\/pnas.88.15.6687","volume":"88","author":"MC Postel-Vinay","year":"1991","unstructured":"Postel-Vinay MC, Belair L, Kayser C, Kelly PA, Djiane J. Identification of prolactin and growth hormone binding proteins in rabbit milk. Proc Natl Acad Sci U S A. 1991;88(15):6687\u201390. https:\/\/doi.org\/10.1073\/pnas.88.15.6687.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9915_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1210\/edrv-17-4-385","volume":"17","author":"V Goffin","year":"1996","unstructured":"Goffin V, Shiverick KT, Kelly PA, Martial JA. Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev. 1996;17(4):385\u2013410. https:\/\/doi.org\/10.1210\/edrv-17-4-385.","journal-title":"Endocr Rev"},{"issue":"4","key":"9915_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/er.2011-1040","volume":"33","author":"CL Brooks","year":"2012","unstructured":"Brooks CL. Molecular mechanisms of prolactin and its receptor. Endocr Rev. 2012;33(4):504\u201325. https:\/\/doi.org\/10.1210\/er.2011-1040.","journal-title":"Endocr Rev"},{"issue":"8","key":"9915_CR41","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1210\/me.2005-0291","volume":"20","author":"AM Qazi","year":"2006","unstructured":"Qazi AM, Tsai-Morris CH, Dufau ML. Ligand-independent homo- and heterodimerization of human prolactin receptor variants: inhibitory action of the short forms by heterodimerization. Mol Endocrinol. 2006;20(8):1912\u201323. https:\/\/doi.org\/10.1210\/me.2005-0291.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"9915_CR42","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrendo.2010.123","volume":"6","author":"AJ Brooks","year":"2010","unstructured":"Brooks AJ, Waters MJ. The growth hormone receptor: mechanism of activation and clinical implications. Nat Rev Endocrinol. 2010;6(9):515\u201325. https:\/\/doi.org\/10.1038\/nrendo.2010.123.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"9915_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","volume":"15","author":"V Bernard","year":"2019","unstructured":"Bernard V, Young J, Binart N. Prolactin \u2014 a pleiotropic factor in health and disease. Nat Rev Endocrinol. 2019;15(6):356\u201365. https:\/\/doi.org\/10.1038\/s41574-019-0194-6.","journal-title":"Nat Rev Endocrinol"},{"issue":"45","key":"9915_CR44","doi-asserted-by":"publisher","first-page":"33118","DOI":"10.1074\/jbc.M704364200","volume":"282","author":"JB Jomain","year":"2007","unstructured":"Jomain JB, Tallet E, Broutin I, Hoos S, van Agthoven J, Ducruix A, et al. Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL. J Biol Chem. 2007;282(45):33118\u201331. https:\/\/doi.org\/10.1074\/jbc.M704364200.","journal-title":"J Biol Chem"},{"issue":"26","key":"9915_CR45","doi-asserted-by":"publisher","first-page":"20022","DOI":"10.1074\/jbc.M109.084988","volume":"285","author":"JL Voorhees","year":"2010","unstructured":"Voorhees JL, Brooks CL. Obligate ordered binding of human lactogenic cytokines. J Biol Chem. 2010;285(26):20022\u201330. https:\/\/doi.org\/10.1074\/jbc.M109.084988.","journal-title":"J Biol Chem"},{"issue":"10","key":"9915_CR46","doi-asserted-by":"publisher","first-page":"4518","DOI":"10.1210\/jc.2009-2815","volume":"95","author":"M Grynberg","year":"2010","unstructured":"Grynberg M, Salenave S, Young J, Chanson P. Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab. 2010;95(10):4518\u201325. https:\/\/doi.org\/10.1210\/jc.2009-2815.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6185","key":"9915_CR47","doi-asserted-by":"publisher","first-page":"1249783","DOI":"10.1126\/science.1249783","volume":"344","author":"AJ Brooks","year":"2014","unstructured":"Brooks AJ, Dai W, O\u2019Mara ML, Abankwa D, Chhabra Y, Pelekanos RA, et al. Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science. 2014;344(6185):1249783. https:\/\/doi.org\/10.1126\/science.1249783.","journal-title":"Science"},{"issue":"3","key":"9915_CR48","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1042\/BJ20141243","volume":"468","author":"GW Haxholm","year":"2015","unstructured":"Haxholm GW, Nikolajsen LF, Olsen JG, Fredsted J, Larsen FH, Goffin V, et al. Intrinsically disordered cytoplasmic domains of two cytokine receptors mediate conserved interactions with membranes. Biochem J. 2015;468(3):495\u2013506. https:\/\/doi.org\/10.1042\/BJ20141243.","journal-title":"Biochem J"},{"issue":"1","key":"9915_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12964-020-00626-6","volume":"18","author":"P Seiffert","year":"2020","unstructured":"Seiffert P, Bugge K, Nygaard M, Haxholm GW, Martinsen JH, Pedersen MN, et al. Orchestration of signaling by structural disorder in class 1 cytokine receptors. Cell Commun Signal. 2020;18(1):132. https:\/\/doi.org\/10.1186\/s12964-020-00626-6.","journal-title":"Cell Commun Signal"},{"key":"9915_CR50","doi-asserted-by":"publisher","unstructured":"Araya-Secchi R, Bugge K, Seiffert P, Petry A, Haxholm GW, Lindorff-Larsen K, et al. The prolactin receptor scaffolds Janus kinase 2 via co-structure formation with phosphoinositide-4,5-bisphosphate. Elife. 2023;12. https:\/\/doi.org\/10.7554\/eLife.84645.","DOI":"10.7554\/eLife.84645"},{"issue":"7","key":"9915_CR51","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1091\/mbc.12.7.2171","volume":"12","author":"J\u00c1F Vara","year":"2001","unstructured":"Vara J\u00c1F, C\u00e1ceres MADN, Silva A, Mart\u0131\u0301N-P\u00e9rez J. Src family kinases are required for Prolactin induction of cell proliferation. Mol Biol Cell. 2001;12(7):2171\u201383. https:\/\/doi.org\/10.1091\/mbc.12.7.2171.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"9915_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cellsig.2009.10.013","volume":"22","author":"JM Garcia-Martinez","year":"2010","unstructured":"Garcia-Martinez JM, Calcabrini A, Gonzalez L, Martin-Forero E, Agullo-Ortuno MT, Simon V, et al. A non-catalytic function of the src family tyrosine kinases controls prolactin-induced Jak2 signaling. Cell Signal. 2010;22(3):415\u201326. https:\/\/doi.org\/10.1016\/j.cellsig.2009.10.013.","journal-title":"Cell Signal"},{"issue":"1","key":"9915_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2001-0036","volume":"24","author":"CV Clevenger","year":"2003","unstructured":"Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev. 2003;24(1):1\u201327. https:\/\/doi.org\/10.1210\/er.2001-0036.","journal-title":"Endocr Rev"},{"issue":"10","key":"9915_CR54","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1210\/mend.11.10.9994","volume":"11","author":"JJ Berlanga","year":"1997","unstructured":"Berlanga JJ, Garcia-Ruiz JP, Perrot-Applanat M, Kelly PA, Edery M. The short form of the prolactin (PRL) receptor silences PRL induction of the beta-casein gene promoter. Mol Endocrinol. 1997;11(10):1449\u201357. https:\/\/doi.org\/10.1210\/mend.11.10.9994.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"9915_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/me.2004-0443","volume":"19","author":"SL Miller","year":"2005","unstructured":"Miller SL, DeMaria JE, Freier DO, Riegel AM, Clevenger CV. Novel association of Vav2 and Nek3 modulates signaling through the human prolactin receptor. Mol Endocrinol. 2005;19(4):939\u201349. https:\/\/doi.org\/10.1210\/me.2004-0443.","journal-title":"Mol Endocrinol"},{"key":"9915_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","volume":"64","author":"V Goffin","year":"2002","unstructured":"Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biology of an old hormone. Annu Rev Physiol. 2002;64:47\u201367. https:\/\/doi.org\/10.1146\/annurev.physiol.64.081501.131049.","journal-title":"Annu Rev Physiol"},{"issue":"21","key":"9915_CR57","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa1307557","volume":"369","author":"PJ Newey","year":"2013","unstructured":"Newey PJ, Gorvin CM, Cleland SJ, Willberg CB, Bridge M, Azharuddin M, et al. Mutant prolactin receptor and familial hyperprolactinemia. N Engl J Med. 2013;369(21):2012\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1307557.","journal-title":"N Engl J Med"},{"issue":"23","key":"9915_CR58","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1805171","volume":"379","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi T, Usui H, Tanaka H, Shozu M. Variant prolactin receptor in Agalactia and Hyperprolactinemia. N Engl J Med. 2018;379(23):2230\u20136. https:\/\/doi.org\/10.1056\/NEJMoa1805171.","journal-title":"N Engl J Med"},{"issue":"2","key":"9915_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/jcem-60-2-258","volume":"60","author":"P Bouchard","year":"1985","unstructured":"Bouchard P, Lagoguey M, Brailly S, Schaison G. Gonadotropin-releasing hormone pulsatile administration restores luteinizing hormone pulsatility and normal testosterone levels in males with hyperprolactinemia. J Clin Endocrinol Metab. 1985;60(2):258\u201362. https:\/\/doi.org\/10.1210\/jcem-60-2-258.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9915_CR60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0301-2115(97)00091-2","volume":"74","author":"P Lecomte","year":"1997","unstructured":"Lecomte P, Lecomte C, Lansac J, Gallier J, Sonier CB, Simonetta C. Pregnancy after intravenous pulsatile gonadotropin-releasing hormone in a hyperprolactinaemic woman resistant to treatment with dopamine agonists. Eur J Obstet Gynecol Reprod Biol. 1997;74(2):219\u201321. https:\/\/doi.org\/10.1016\/s0301-2115(97)00091-2.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"9915_CR61","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/jcem-59-5-941","volume":"59","author":"SE Sauder","year":"1984","unstructured":"Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab. 1984;59(5):941\u20138. https:\/\/doi.org\/10.1210\/jcem-59-5-941.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"9915_CR62","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1210\/en.2007-0403","volume":"148","author":"DR Grattan","year":"2007","unstructured":"Grattan DR, Jasoni CL, Liu X, Anderson GM, Herbison AE. Prolactin regulation of gonadotropin-releasing hormone neurons to suppress luteinizing hormone secretion in mice. Endocrinology. 2007;148(9):4344\u201351. https:\/\/doi.org\/10.1210\/en.2007-0403.","journal-title":"Endocrinology"},{"issue":"10","key":"9915_CR63","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1365-2826.2011.02195.x","volume":"23","author":"Q Li","year":"2011","unstructured":"Li Q, Rao A, Pereira A, Clarke IJ, Smith JT. Kisspeptin cells in the ovine arcuate nucleus express prolactin receptor but not melatonin receptor. J Neuroendocrinol. 2011;23(10):871\u201382. https:\/\/doi.org\/10.1111\/j.1365-2826.2011.02195.x.","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"9915_CR64","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1210\/en.2010-1225","volume":"152","author":"JT Smith","year":"2011","unstructured":"Smith JT, Li Q, Yap KS, Shahab M, Roseweir AK, Millar RP, et al. Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology. 2011;152(3):1001\u201312. https:\/\/doi.org\/10.1210\/en.2010-1225.","journal-title":"Endocrinology"},{"issue":"2","key":"9915_CR65","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1210\/en.2010-0668","volume":"152","author":"IC Kokay","year":"2011","unstructured":"Kokay IC, Petersen SL, Grattan DR. Identification of prolactin-sensitive GABA and kisspeptin neurons in regions of the rat hypothalamus involved in the control of fertility. Endocrinology. 2011;152(2):526\u201335. https:\/\/doi.org\/10.1210\/en.2010-0668.","journal-title":"Endocrinology"},{"issue":"10","key":"9915_CR66","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1172\/JCI63937","volume":"122","author":"C Sonigo","year":"2012","unstructured":"Sonigo C, Bouilly J, Carre N, Tolle V, Caraty A, Tello J, et al. Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest. 2012;122(10):3791\u20135. https:\/\/doi.org\/10.1172\/JCI63937.","journal-title":"J Clin Invest"},{"issue":"11","key":"9915_CR67","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1210\/js.2017-00328","volume":"1","author":"RP Millar","year":"2017","unstructured":"Millar RP, Sonigo C, Anderson RA, George J, Maione L, Brailly-Tabard S, et al. Hypothalamic-pituitary-ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women with Chronic Amenorrhea. J Endocr Soc. 2017;1(11):1362\u201371. https:\/\/doi.org\/10.1210\/js.2017-00328.","journal-title":"J Endocr Soc"},{"issue":"8","key":"9915_CR68","doi-asserted-by":"publisher","first-page":"e3515","DOI":"10.1210\/clinem\/dgac166","volume":"107","author":"K Hoskova","year":"2022","unstructured":"Hoskova K, Kayton Bryant N, Chen ME, Nachtigall LB, Lippincott MF, Balasubramanian R, et al. Kisspeptin overcomes GnRH neuronal suppression secondary to hyperprolactinemia in humans. J Clin Endocrinol Metab. 2022;107(8):e3515\u201325. https:\/\/doi.org\/10.1210\/clinem\/dgac166.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9915_CR69","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41574-022-00742-y","volume":"19","author":"FM Hannan","year":"2023","unstructured":"Hannan FM, Elajnaf T, Vandenberg LN, Kennedy SH, Thakker RV. Hormonal regulation of mammary gland development and lactation. Nat Rev Endocrinol. 2023;19(1):46\u201361. https:\/\/doi.org\/10.1038\/s41574-022-00742-y.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"9915_CR70","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1515\/cclm-2017-0644","volume":"56","author":"Y Hu","year":"2018","unstructured":"Hu Y, Ding Y, Yang M, Xiang Z. Serum prolactin levels across pregnancy and the establishment of reference intervals. Clin Chem Lab Med. 2018;56(5):838\u201342. https:\/\/doi.org\/10.1515\/cclm-2017-0644.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"9915_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1023\/a:1026395229025","volume":"2","author":"CJ Ormandy","year":"1997","unstructured":"Ormandy CJ, Binart N, Kelly PA. Mammary gland development in prolactin receptor knockout mice. J Mammary Gland Biol Neoplasia. 1997;2(4):355\u201364. https:\/\/doi.org\/10.1023\/a:1026395229025.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"9915_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/dbio.2000.9961","volume":"229","author":"MI Gallego","year":"2001","unstructured":"Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol. 2001;229(1):163\u201375. https:\/\/doi.org\/10.1006\/dbio.2000.9961.","journal-title":"Dev Biol"},{"issue":"8","key":"9915_CR73","doi-asserted-by":"publisher","first-page":"e3021","DOI":"10.1210\/clinem\/dgab201","volume":"106","author":"M Moriwaki","year":"2021","unstructured":"Moriwaki M, Welt CK. PRL mutation causing alactogenesis: insights into Prolactin structure and function relationships. J Clin Endocrinol Metab. 2021;106(8):e3021\u20136. https:\/\/doi.org\/10.1210\/clinem\/dgab201.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9915_CR74","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1210\/jcem.86.8.7723","volume":"86","author":"J Deladoey","year":"2001","unstructured":"Deladoey J, Stocker P, Mullis PE. Autosomal dominant GH deficiency due to an Arg183His GH-1 gene mutation: clinical and molecular evidence of impaired regulated GH secretion. J Clin Endocrinol Metab. 2001;86(8):3941\u20137. https:\/\/doi.org\/10.1210\/jcem.86.8.7723.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9915_CR75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1530\/rep.0.1230497","volume":"123","author":"D Grattan","year":"2002","unstructured":"Grattan D. Behavioural significance of prolactin signalling in the central nervous system during pregnancy and lactation. Reproduction. 2002;123(4):497\u2013506. https:\/\/doi.org\/10.1530\/rep.0.1230497.","journal-title":"Reproduction"},{"key":"9915_CR76","doi-asserted-by":"publisher","unstructured":"Georgescu T, Swart JM, Grattan DR, Brown RSE. The Prolactin Family of hormones as regulators of maternal Mood and Behavior. Front Glob Womens Health. 2021;2. https:\/\/doi.org\/10.3389\/fgwh.2021.767467.","DOI":"10.3389\/fgwh.2021.767467"},{"issue":"10","key":"9915_CR77","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1210\/endo.139.10.6243","volume":"139","author":"BK Lucas","year":"1998","unstructured":"Lucas BK, Ormandy CJ, Binart N, Bridges RS, Kelly PA. Null mutation of the prolactin receptor gene produces a defect in maternal behavior. Endocrinology. 1998;139(10):4102\u20137. https:\/\/doi.org\/10.1210\/endo.139.10.6243.","journal-title":"Endocrinology"},{"issue":"1","key":"9915_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000127098","volume":"64","author":"RS Bridges","year":"1996","unstructured":"Bridges RS, Robertson MC, Shiu RP, Friesen HG, Stuer AM, Mann PE. Endocrine communication between conceptus and mother: placental lactogen stimulation of maternal behavior. Neuroendocrinology. 1996;64(1):57\u201364. https:\/\/doi.org\/10.1159\/000127098.","journal-title":"Neuroendocrinology"},{"issue":"40","key":"9915_CR79","doi-asserted-by":"publisher","first-page":"10779","DOI":"10.1073\/pnas.1708025114","volume":"114","author":"RSE Brown","year":"2017","unstructured":"Brown RSE, Aoki M, Ladyman SR, Phillipps HR, Wyatt A, Boehm U, et al. Prolactin action in the medial preoptic area is necessary for postpartum maternal nursing behavior. Proc Natl Acad Sci U S A. 2017;114(40):10779\u201384. https:\/\/doi.org\/10.1073\/pnas.1708025114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"9915_CR80","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.yhbeh.2009.06.005","volume":"56","author":"AI Melo","year":"2009","unstructured":"Melo AI, Perez-Ledezma M, Clapp C, Arnold E, Rivera JC, Fleming AS. Effects of prolactin deficiency during the early postnatal period on the development of maternal behavior in female rats: mother\u2019s milk makes the difference. Horm Behav. 2009;56(3):281\u201391. https:\/\/doi.org\/10.1016\/j.yhbeh.2009.06.005.","journal-title":"Horm Behav"},{"issue":"49","key":"9915_CR81","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1073\/pnas.1621196114","volume":"114","author":"TJ Sairenji","year":"2017","unstructured":"Sairenji TJ, Ikezawa J, Kaneko R, Masuda S, Uchida K, Takanashi Y, et al. Maternal prolactin during late pregnancy is important in generating nurturing behavior in the offspring. Proc Natl Acad Sci U S A. 2017;114(49):13042\u20137. https:\/\/doi.org\/10.1073\/pnas.1621196114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"9915_CR82","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1159\/000510038","volume":"111","author":"H Salais-L\u00f3pez","year":"2021","unstructured":"Salais-L\u00f3pez H, Abell\u00e1n-\u00c1lvaro M, Bell\u00e9s M, Lanuza E, Agustin-Pavon C, Mart\u00ednez-Garc\u00eda F. Maternal motivation: exploring the roles of Prolactin and Pup Stimuli. Neuroendocrinology. 2021;111(9):805\u201330. https:\/\/doi.org\/10.1159\/000510038.","journal-title":"Neuroendocrinology"},{"issue":"6","key":"9915_CR83","doi-asserted-by":"publisher","first-page":"e2116972119","DOI":"10.1073\/pnas.2116972119","volume":"119","author":"T Georgescu","year":"2022","unstructured":"Georgescu T, Khant Aung Z, Grattan DR, Brown RSE. Prolactin-mediated restraint of maternal aggression in lactation. Proc Natl Acad Sci USA. 2022;119(6):e2116972119. https:\/\/doi.org\/10.1073\/pnas.2116972119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9915_CR84","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00429-016-1254-5","volume":"222","author":"H Salais-Lopez","year":"2017","unstructured":"Salais-Lopez H, Lanuza E, Agustin-Pavon C, Martinez-Garcia F. Tuning the brain for motherhood: prolactin-like central signalling in virgin, pregnant, and lactating female mice. Brain Struct Funct. 2017;222(2):895\u2013921. https:\/\/doi.org\/10.1007\/s00429-016-1254-5.","journal-title":"Brain Struct Funct"},{"issue":"6","key":"9915_CR85","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.tem.2010.01.008","volume":"21","author":"N Binart","year":"2010","unstructured":"Binart N, Bachelot A, Bouilly J. Impact of prolactin receptor isoforms on reproduction. Trends Endocrinol Metab. 2010;21(6):362\u20138. https:\/\/doi.org\/10.1016\/j.tem.2010.01.008.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"9915_CR86","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/s0015-0282(97)00320-8","volume":"68","author":"P Schwarzler","year":"1997","unstructured":"Schwarzler P, Untergasser G, Hermann M, Dirnhofer S, Abendstein B, Berger P. Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril. 1997;68(4):696\u2013701. https:\/\/doi.org\/10.1016\/s0015-0282(97)00320-8.","journal-title":"Fertil Steril"},{"issue":"11","key":"9915_CR87","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/molehr\/7.11.1033","volume":"7","author":"NP Vlahos","year":"2001","unstructured":"Vlahos NP, Bugg EM, Shamblott MJ, Phelps JY, Gearhart JD, Zacur HA. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells. Mol Hum Reprod. 2001;7(11):1033\u20138. https:\/\/doi.org\/10.1093\/molehr\/7.11.1033.","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"9915_CR88","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ando.2022.04.002","volume":"83","author":"D Maiter","year":"2022","unstructured":"Maiter D. Mild hyperprolactinemia in a couple: what impact on fertility? Ann Endocrinol (Paris). 2022;83(3):164\u20137. https:\/\/doi.org\/10.1016\/j.ando.2022.04.002.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"7953","key":"9915_CR89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0140-6736(76)91343-x","volume":"1","author":"M Seppala","year":"1976","unstructured":"Seppala M, Ranta T, Hirvonen E. Hyperprolactinaemia and luteal insufficiency. Lancet. 1976;1(7953):229\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(76)91343-x.","journal-title":"Lancet"},{"issue":"4","key":"9915_CR90","first-page":"651","volume":"78","author":"KE Huang","year":"1991","unstructured":"Huang KE, Bonfiglio TA, Muechler EK. Transient hyperprolactinemia in infertile women with luteal phase deficiency. Obstet Gynecol. 1991;78(4):651\u20135.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"9915_CR91","doi-asserted-by":"publisher","first-page":"CD008883","DOI":"10.1002\/14651858.CD008883.pub2","volume":"7","author":"H Chen","year":"2016","unstructured":"Chen H, Fu J, Huang W. Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history. Cochrane Database Syst Rev. 2016;7(7):CD008883. https:\/\/doi.org\/10.1002\/14651858.CD008883.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"9915_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/head.14248","volume":"62","author":"BN Mason","year":"2022","unstructured":"Mason BN, Kallianpur R, Price TJ, Akopian AN, Dussor GO. Prolactin signaling modulates stress-induced behavioral responses in a preclinical mouse model of migraine. Headache. 2022;62(1):11\u201325. https:\/\/doi.org\/10.1111\/head.14248.","journal-title":"Headache"},{"issue":"6","key":"9915_CR93","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/ana.26070","volume":"89","author":"A Avona","year":"2021","unstructured":"Avona A, Mason BN, Burgos-Vega C, Hovhannisyan AH, Belugin SN, Mecklenburg J, et al. Meningeal CGRP-Prolactin Interaction evokes female-specific migraine behavior. Ann Neurol. 2021;89(6):1129\u201344. https:\/\/doi.org\/10.1002\/ana.26070.","journal-title":"Ann Neurol"},{"issue":"5","key":"9915_CR94","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41582-021-00491-y","volume":"17","author":"S Lempri\u00e8re","year":"2021","unstructured":"Lempri\u00e8re S. Crosstalk between prolactin and CGRP signalling contributes to migraine in females. Nat Rev Neurol. 2021;17(5):261. https:\/\/doi.org\/10.1038\/s41582-021-00491-y.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"9915_CR95","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10194-011-0306-8","volume":"12","author":"S Guldiken","year":"2011","unstructured":"Guldiken S, Guldiken B, Demir M, Kabayel L, Ozkan H, Turgut N, et al. Soluble CD40 ligand and prolactin levels in migraine patients during interictal period. J Headache Pain. 2011;12(3):355\u201360. https:\/\/doi.org\/10.1007\/s10194-011-0306-8.","journal-title":"J Headache Pain"},{"issue":"7","key":"9915_CR96","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1526-4610.1995.hed3507430.x","volume":"35","author":"N Hartman","year":"1995","unstructured":"Hartman N, Voron SC, Hershman JM. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma). Headache. 1995;35(7):430\u20131. https:\/\/doi.org\/10.1111\/j.1526-4610.1995.hed3507430.x.","journal-title":"Headache"},{"issue":"4","key":"9915_CR97","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1468-2982.1995.1504292.x","volume":"15","author":"ML Gordon","year":"1995","unstructured":"Gordon ML, Lipton RB, Brown SL, van Praag HM. The neuroendocrine challenge paradigm in headache research. Cephalalgia. 1995;15(4):292\u20136. https:\/\/doi.org\/10.1046\/j.1468-2982.1995.1504292.x.","journal-title":"Cephalalgia"},{"issue":"2","key":"9915_CR98","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10194-008-0016-z","volume":"9","author":"D Bosco","year":"2008","unstructured":"Bosco D, Belfiore A, Fava A, De Rose M, Plastino M, Ceccotti C, et al. Relationship between high prolactin levels and migraine attacks in patients with microprolactinoma. J Headache Pain. 2008;9(2):103\u20137. https:\/\/doi.org\/10.1007\/s10194-008-0016-z.","journal-title":"J Headache Pain"},{"issue":"6","key":"9915_CR99","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1210\/endo-45-6-627","volume":"45","author":"BA Houssay","year":"1949","unstructured":"Houssay BA, Anderson E. Diabetogenic action of purified anterior pituitary hormones. Endocrinology. 1949;45(6):627\u20139. https:\/\/doi.org\/10.1210\/endo-45-6-627.","journal-title":"Endocrinology"},{"issue":"4","key":"9915_CR100","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","volume":"31","author":"Y Macotela","year":"2020","unstructured":"Macotela Y, Triebel J, Clapp C. Time for a New Perspective on Prolactin in Metabolism. Trends Endocrinol Metab. 2020;31(4):276\u201386. https:\/\/doi.org\/10.1016\/j.tem.2020.01.004.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"9915_CR101","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1210\/en.2007-1018","volume":"149","author":"RA Augustine","year":"2008","unstructured":"Augustine RA, Grattan DR. Induction of central leptin resistance in hyperphagic pseudopregnant rats by chronic prolactin infusion. Endocrinology. 2008;149(3):1049\u201355. https:\/\/doi.org\/10.1210\/en.2007-1018.","journal-title":"Endocrinology"},{"issue":"8","key":"9915_CR102","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.2337\/db15-1527","volume":"65","author":"RR Banerjee","year":"2016","unstructured":"Banerjee RR, Cyphert HA, Walker EM, Chakravarthy H, Peiris H, Gu X, et al. Gestational diabetes Mellitus from inactivation of prolactin receptor and MafB in Islet beta-cells. Diabetes. 2016;65(8):2331\u201341. https:\/\/doi.org\/10.2337\/db15-1527.","journal-title":"Diabetes"},{"issue":"Pt 2","key":"9915_CR103","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1042\/bj2850469","volume":"285","author":"MC Barber","year":"1992","unstructured":"Barber MC, Travers MT, Finley E, Flint DJ, Vernon RG. Growth-hormone-prolactin interactions in the regulation of mammary and adipose-tissue acetyl-CoA carboxylase activity and gene expression in lactating rats. Biochem J. 1992;285(Pt 2):469\u201375. https:\/\/doi.org\/10.1042\/bj2850469.","journal-title":"Biochem J"},{"issue":"11","key":"9915_CR104","doi-asserted-by":"publisher","first-page":"e12888","DOI":"10.1111\/jne.12888","volume":"32","author":"F Lopez-Vicchi","year":"2020","unstructured":"Lopez-Vicchi F, De Winne C, Brie B, Sorianello E, Ladyman SR, Becu-Villalobos D. Metabolic functions of prolactin: physiological and pathological aspects. J Neuroendocrinol. 2020;32(11):e12888. https:\/\/doi.org\/10.1111\/jne.12888.","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"9915_CR105","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1096\/fj.201902357R","volume":"34","author":"F Lopez-Vicchi","year":"2020","unstructured":"Lopez-Vicchi F, Ladyman SR, Ornstein AM, Gustafson P, Knowles P, Luque GM, et al. Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake. FASEB J. 2020;34(3):3902\u201314. https:\/\/doi.org\/10.1096\/fj.201902357R.","journal-title":"FASEB J"},{"issue":"12","key":"9915_CR106","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1007\/s00125-018-4733-9","volume":"61","author":"J Li","year":"2018","unstructured":"Li J, Rice MS, Huang T, Hankinson SE, Clevenger CV, Hu FB, et al. Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia. 2018;61(12):2549\u201360. https:\/\/doi.org\/10.1007\/s00125-018-4733-9.","journal-title":"Diabetologia"},{"key":"9915_CR107","doi-asserted-by":"publisher","unstructured":"Triebel J, Robles-Osorio ML, Garcia-Franco R, De La Mart\u00ednez G, Clapp C, Bertsch T. From bench to Bedside: translating the Prolactin\/Vasoinhibin Axis. Front Endocrinol (Lausanne). 2017;8. https:\/\/doi.org\/10.3389\/fendo.2017.00342.","DOI":"10.3389\/fendo.2017.00342"},{"issue":"3","key":"9915_CR108","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11897-012-0095-7","volume":"9","author":"D Hilfiker-Kleiner","year":"2012","unstructured":"Hilfiker-Kleiner D, Struman I, Hoch M, Podewski E, Sliwa K. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy. Curr Heart Fail Rep. 2012;9(3):174\u201382. https:\/\/doi.org\/10.1007\/s11897-012-0095-7.","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"9915_CR109","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1210\/mend.13.5.0280","volume":"13","author":"G D\u2019Angelo","year":"1999","unstructured":"D\u2019Angelo G, Martini JF, Iiri T, Fantl WJ, Martial J, Weiner RI. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol Endocrinol. 1999;13(5):692\u2013704. https:\/\/doi.org\/10.1210\/mend.13.5.0280.","journal-title":"Mol Endocrinol"},{"issue":"9","key":"9915_CR110","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/me.2003-0132","volume":"17","author":"SP Tabruyn","year":"2003","unstructured":"Tabruyn SP, Sorlet CM, Rentier-Delrue F, Bours V, Weiner RI, Martial JA, et al. The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappab. Mol Endocrinol. 2003;17(9):1815\u201323. https:\/\/doi.org\/10.1210\/me.2003-0132.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"9915_CR111","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1210\/me.2004-0515","volume":"19","author":"SP Tabruyn","year":"2005","unstructured":"Tabruyn SP, Nguyen NQ, Cornet AM, Martial JA, Struman I. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases. Mol Endocrinol. 2005;19(7):1932\u201342. https:\/\/doi.org\/10.1210\/me.2004-0515.","journal-title":"Mol Endocrinol"},{"issue":"6","key":"9915_CR112","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1172\/JCI34508","volume":"118","author":"C Garcia","year":"2008","unstructured":"Garcia C, Aranda J, Arnold E, Thebault S, Macotela Y, Lopez-Casillas F, et al. Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation. J Clin Invest. 2008;118(6):2291\u2013300. https:\/\/doi.org\/10.1172\/JCI34508.","journal-title":"J Clin Invest"},{"issue":"12","key":"9915_CR113","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.2337\/db10-0873","volume":"59","author":"E Arnold","year":"2010","unstructured":"Arnold E, Rivera JC, Thebault S, Moreno-P\u00e1ramo D, Quiroz-Mercado H, Quintanar-St\u00e9phano A, et al. High Levels of Serum Prolactin Protect against Diabetic Retinopathy by increasing ocular vasoinhibins. Diabetes. 2010;59(12):3192\u20137. https:\/\/doi.org\/10.2337\/db10-0873.","journal-title":"Diabetes"},{"issue":"8","key":"9915_CR114","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41569-021-00664-8","volume":"19","author":"MF Hoes","year":"2022","unstructured":"Hoes MF, Arany Z, Bauersachs J, Hilfiker-Kleiner D, Petrie MC, Sliwa K, et al. Pathophysiology and risk factors of peripartum cardiomyopathy. Nat Rev Cardiol. 2022;19(8):555\u201365. https:\/\/doi.org\/10.1038\/s41569-021-00664-8.","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"9915_CR115","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/jci64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein J, Tabruyn SP, Ricke-Hoch M, Haghikia A, Nguyen N-Q-N, Scherr M, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013;123(5):2143\u201354. https:\/\/doi.org\/10.1172\/jci64365.","journal-title":"J Clin Invest"},{"issue":"12","key":"9915_CR116","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ejhf.808","volume":"19","author":"D Hilfiker-Kleiner","year":"2017","unstructured":"Hilfiker-Kleiner D, Haghikia A, Masuko D, Nonhoff J, Held D, Libhaber E, et al. Outcome of subsequent pregnancies in patients with a history of peripartum cardiomyopathy. Eur J Heart Fail. 2017;19(12):1723\u20138. https:\/\/doi.org\/10.1002\/ejhf.808.","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"9915_CR117","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41574-023-00894-5","volume":"19","author":"M Zaidi","year":"2023","unstructured":"Zaidi M, Yuen T, Kim SM. Pituitary crosstalk with bone, adipose tissue and brain. Nat Rev Endocrinol. 2023;19(12):708\u201321. https:\/\/doi.org\/10.1038\/s41574-023-00894-5.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"9915_CR118","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/endo.140.1.6436","volume":"140","author":"P Cl\u00e9ment-Lacroix","year":"1999","unstructured":"Cl\u00e9ment-Lacroix P, Ormandy C, Lepescheux Ln, Ammann P, Damotte D, Goffin V, et al. Osteoblasts are a New Target for Prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology. 1999;140(1):96\u2013105. https:\/\/doi.org\/10.1210\/endo.140.1.6436.","journal-title":"Endocrinology"},{"issue":"15","key":"9915_CR119","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00018-016-2187-0","volume":"73","author":"C Clapp","year":"2016","unstructured":"Clapp C, Adan N, Ledesma-Colunga MG, Solis-Gutierrez M, Triebel J, Martinez de la Escalera G. The role of the prolactin\/vasoinhibin axis in rheumatoid arthritis: an integrative overview. Cell Mol Life Sci. 2016;73(15):2929\u201348. https:\/\/doi.org\/10.1007\/s00018-016-2187-0.","journal-title":"Cell Mol Life Sci"},{"key":"9915_CR120","doi-asserted-by":"publisher","unstructured":"Clapp C, Ortiz G, Garc\u00eda-Rodrigo JF, Ledesma-Colunga MG, Mart\u00ednez-D\u00edaz OF, Ad\u00e1n N, et al. Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis. Front Endocrinol (Lausanne). 2022;13. https:\/\/doi.org\/10.3389\/fendo.2022.905756.","DOI":"10.3389\/fendo.2022.905756"},{"issue":"5","key":"9915_CR121","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/art.1780250517","volume":"25","author":"I Berczi","year":"1982","unstructured":"Berczi I, Nagy E. A possible role of prolactin in adjuvant arthritis. Arthritis Rheum. 1982;25(5):591\u20134. https:\/\/doi.org\/10.1002\/art.1780250517.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"9915_CR122","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41374-020-0432-5","volume":"100","author":"G Ortiz","year":"2020","unstructured":"Ortiz G, Ledesma-Colunga MG, Wu Z, Garcia-Rodrigo JF, Adan N, de la Martinez G, et al. Vasoinhibin reduces joint inflammation, bone loss, and the angiogenesis and vasopermeability of the pannus in murine antigen-induced arthritis. Lab Invest. 2020;100(8):1068\u201379. https:\/\/doi.org\/10.1038\/s41374-020-0432-5.","journal-title":"Lab Invest"},{"issue":"8","key":"9915_CR123","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1191\/096120301701549688","volume":"10","author":"AM Jacobi","year":"2001","unstructured":"Jacobi AM, Rohde W, Ventz M, Riemekasten G, Burmester GR, Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus. 2001;10(8):554\u201361. https:\/\/doi.org\/10.1191\/096120301701549688.","journal-title":"Lupus"},{"issue":"10","key":"9915_CR124","first-page":"2216","volume":"28","author":"M Pacilio","year":"2001","unstructured":"Pacilio M, Migliaresi S, Meli R, Ambrosone L, Bigliardo B, Di Carlo R. Elevated bioactive prolactin levels in systemic lupus erythematosus\u2013association with disease activity. J Rheumatol. 2001;28(10):2216\u201321.","journal-title":"J Rheumatol"},{"key":"9915_CR125","doi-asserted-by":"publisher","unstructured":"Legorreta-Haquet MV, Santana-S\u00e1nchez P, Ch\u00e1vez-S\u00e1nchez L, Ch\u00e1vez-Rueda AK. The effect of prolactin on immune cell subsets involved in SLE pathogenesis. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1016427.","DOI":"10.3389\/fimmu.2022.1016427"},{"key":"9915_CR126","doi-asserted-by":"publisher","unstructured":"Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin and autoimmunity. Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.00073.","DOI":"10.3389\/fimmu.2018.00073"},{"key":"9915_CR127","doi-asserted-by":"publisher","unstructured":"Clevenger CV, Rui H. Breast Cancer and prolactin\u2013 new mechanisms and models. Endocrinology. 2022;163(10). https:\/\/doi.org\/10.1210\/endocr\/bqac122.","DOI":"10.1210\/endocr\/bqac122"},{"issue":"5","key":"9915_CR128","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrendo.2015.36","volume":"11","author":"V Bernard","year":"2015","unstructured":"Bernard V, Young J, Chanson P, Binart N. New insights in prolactin: pathological implications. Nat Rev Endocrinol. 2015;11(5):265\u201375. https:\/\/doi.org\/10.1038\/nrendo.2015.36.","journal-title":"Nat Rev Endocrinol"},{"key":"9915_CR129","doi-asserted-by":"publisher","unstructured":"Standing D, Dandawate P, Anant S. Prolactin receptor signaling: a novel target for cancer treatment - exploring anti-PRLR signaling strategies. Front Endocrinol (Lausanne). 2023;13. https:\/\/doi.org\/10.3389\/fendo.2022.1112987.","DOI":"10.3389\/fendo.2022.1112987"},{"issue":"9","key":"9915_CR130","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.21873\/anticanres.14526","volume":"40","author":"H Minami","year":"2020","unstructured":"Minami H, Ando Y, Tamura K, Tajima T, Isaacs R. Phase I study of LFA102 in patients with advanced breast Cancer or castration-resistant prostate Cancer. Anticancer Res. 2020;40(9):5229\u201335. https:\/\/doi.org\/10.21873\/anticanres.14526.","journal-title":"Anticancer Res"},{"key":"9915_CR131","doi-asserted-by":"publisher","unstructured":"Grible JM, Zot P, Olex AL, Hedrick SE, Harrell JC, Woock AE, et al. The human intermediate prolactin receptor is a mammary proto-oncogene. NPJ Breast Cancer. 2021;7(1). https:\/\/doi.org\/10.1038\/s41523-021-00243-7.","DOI":"10.1038\/s41523-021-00243-7"},{"key":"9915_CR132","doi-asserted-by":"publisher","unstructured":"Sun Y, Yang N, Utama FE, Udhane SS, Zhang J, Peck AR, et al. NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers. Sci Adv. 2021;7(38). https:\/\/doi.org\/10.1126\/sciadv.abc8145.","DOI":"10.1126\/sciadv.abc8145"},{"key":"9915_CR133","doi-asserted-by":"publisher","unstructured":"Taghi Khani A, Kumar A, Sanchez Ortiz A, Radecki KC, Aramburo S, Lee SJ, et al. Isoform-specific knockdown of long and intermediate prolactin receptors interferes with evolution of B-cell neoplasms. Commun Biol. 2023;6(1). https:\/\/doi.org\/10.1038\/s42003-023-04667-8.","DOI":"10.1038\/s42003-023-04667-8"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-024-09915-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-024-09915-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T15:06:50Z","timestamp":1733584010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-024-09915-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9915"],"URL":"https:\/\/doi.org\/10.1007\/s11154-024-09915-8","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"6 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The Authors declare that they have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}